tldrdailynews.com logo

FDA Approves Moderna's RSV Vaccine for Seniors

1 min read
Source: Financial Times
TL;DR

Moderna has received its second approval for a vaccine targeting respiratory syncytial virus (RSV) infection.

Topics:top-newshealth#approval#health#moderna#rsv#vaccine
Share this article
  1. Moderna wins second approval with vaccine targeting RSV infection  Financial Times
  2. FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product  CNBC
  3. FDA approves Moderna’s mRNA RSV vaccine for older adults  CNN
  4. Moderna secures FDA approval for RSV vaccine mRESVIA  FiercePharma
  5. Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine  Yahoo Finance

Want the full story? Read the original reporting

Read on Financial Times